PATENT CLAIM ANALYSIS

Application Number: 16139672
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "474000"]

Abstract:
The invention relates to tablet comprising granules dispersed in at least one hydrophilic compound or matrix. The granules contain an active agent, at least one amphiphilic compound and at least one lipophilic compound. The tablet may include a gastro-resistant film coating.

Claim (Index 3):
A controlled release oral pharmaceutical composition consisting essentially of:\n (1) a tableted core consisting of a dispersion of ingredients, said ingredients comprising:\n a) budesonide in an amount to treat intestinal inflammation; \n b) magnesium stearate, stearic acid, or a mixture thereof; \n c) hydroxyalkyl cellulose; and \n d) optionally starch or a starch derivative; and \n (2) a coating on said tableted core, said coating consisting essentially of a gastro-resistant film.

Metadata:
- Claim Count in Document: 82.0
- Percentile: 97.0
- Lexical Diversity: 1.45161
- Patent Class: 424.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15646538', '15646330', '15369296', '14308279', '14308305']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8113029472145652
- 35 USC 102 Novelty (BERT): 0.5563124814548109
- Combined Prediction Score: 0.7858039006385897
- Mean Citation Score: 428.86546
- Max Citation Score: 443.2943
- Similarity Product: 427.56205997603536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test